Seniors with cancer respond just as well as younger patients to immune checkpoint inhibitors -- drugs that take the brakes ...

Nigel McCracken, chief operating officer, Virax Biolabs, discusses the expansion of its ViraxImmune platform into areas such as transplant monitoring, vaccine efficacy, latent virus reactivation, and ...

Seniors with cancer respond just as well as younger patients to immune checkpoint inhibitors — drugs that take the brakes off ...

An allergy is an abnormal immune system response which causes the body to overreact to a usually harmless substance ...

T-cell activation involves two phases, enabling a more precise immune response. This insight may boost cancer immunotherapy effectiveness. A research team led by Wolfgang Kastenmüller and Georg ...

When the immune system does not function properly, individuals become more susceptible to infections caused by viruses, ...

Researchers have developed an innovative nano-immune agonist that significantly improves immunotherapy outcomes for melanoma—a highly aggressive and hard-to-treat form of skin cancer.

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a new study.

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune ...

Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these immune proteins can do more than that: They also activate other components of ...

An allergy is an abnormal immune system response which causes the body to overreact to a usually harmless substance ...

Rodents fed a diet high in soluble fiber showed improved resistance to a microorganism that causes diarrhea and can be fatal ...